Meet
Features
Solutions
Pricing
Sales Intelligence
Qualify prospects and connect with decision makers effortlessly
Research Companies & Directors
Make important decisions with absolute confidence
Create B2B Marketing Lists
Target and reach more of your ideal prospects than ever
Monitor Risks & Opportunities
Be the first to learn about changes in the companies that matter
Cleanse Your B2B Database
Instantly transform old records into new opportunities
Perform KYC Checks
Completely understand who you're working with
Discover New Businesses
Identify and connect with new companies as soon as they register
Company Credit Reports
See how companies are performing year–on–year and explore their debts
UPGRADE
Contact
Credit Report
Financials
People
Ownership
Latest Activity
Mutual Companies
Documents
Repayment History
Re-Aim Therapeutics Ltd
Re-Aim Therapeutics Ltd is an active company incorporated on 29 April 2024 with the registered office located in Oxford, Oxfordshire. Re-Aim Therapeutics Ltd was registered 1 year 5 months ago.
Watch Company
Status
Active
Active since
incorporation
Company No
15689618
Private limited company
Age
1 year 5 months
Incorporated
29 April 2024
Size
Micro
Turnover is under
£1M
Balance sheet is under
£500,000
Under
10 employees
Confirmation
Submitted
Dated
28 April 2025
(5 months ago)
Next confirmation dated
28 April 2026
Due by
12 May 2026
(6 months remaining)
Last change occurred
5 months ago
Accounts
Not Submitted
Awaiting first accounts
For period ending
30 April 2025
Due by
29 January 2026
(3 months remaining)
Learn more about Re-Aim Therapeutics Ltd
Contact
Update Details
Address
Innovation Building Old Campus Road
Roosevelt Drive
Oxford
OX3 7FZ
England
Address changed on
9 Jul 2025
(3 months ago)
Previous address was
35 Ballards Lane London N3 1XW United Kingdom
Companies in OX3 7FZ
Telephone
Unreported
Email
Unreported
Website
Unreported
See All Contacts
People
Officers
6
Shareholders
10
Controllers (PSC)
1
Dr Asher Maroof
Director • PSC • British • Lives in UK • Born in Sep 1976
Jason Goldstein
Director • British • Lives in UK • Born in Jun 1991
John Tsai
Director • American • Lives in Switzerland • Born in Sep 1967
Justian Craig Fox
Director • British • Lives in England • Born in Nov 1975
Roel Bulthuis
Director • Dutch • Lives in Netherlands • Born in Mar 1976
See Key People
Shareholders, PSCs & Group Structure
See who truly controls a company with full PSC, Shareholder, and Group Structure exploration
See All Shareholders, PSCs & Group Structure
Mutual Companies
Dark Blue Therapeutics Ltd
Justian Craig Fox is a mutual person.
Active
NG Bio Ltd
Jason Goldstein is a mutual person.
Active
Kesmalea Therapeutics Limited
Justian Craig Fox is a mutual person.
Active
Mesenbio Limited
Jason Goldstein is a mutual person.
Active
Isogenix Limited
Justian Craig Fox is a mutual person.
Active
Matchbio Limited
Justian Craig Fox is a mutual person.
Active
Kodiform Therapeutics Limited
Justian Craig Fox is a mutual person.
Active
Solute Guard Therapeutics Limited
Jason Goldstein is a mutual person.
Active
See All Mutual Companies
Financials
Re-Aim Therapeutics Ltd has not yet submitted any accounts
Period Ended
Due Soon
Cash in Bank
Due Soon
Turnover
Due Soon
Employees
Due Soon
Total Assets
Due Soon
Total Liabilities
Due Soon
Net Assets
Due Soon
Debt Ratio (%)
Due Soon
See 10 Year Full Financials
Latest Activity
Accounting Period Shortened
15 Days Ago on 9 Oct 2025
Mr Roel Bulthuis Appointed
22 Days Ago on 2 Oct 2025
Mr Pierre-Louis Emmanuel Joffrin Appointed
22 Days Ago on 2 Oct 2025
Mr John Tsai Appointed
22 Days Ago on 2 Oct 2025
Mr Justian Craig Fox Appointed
22 Days Ago on 2 Oct 2025
Jason Goldstein Resigned
22 Days Ago on 2 Oct 2025
Registered Address Changed
3 Months Ago on 9 Jul 2025
Confirmation Submitted
5 Months Ago on 28 Apr 2025
Incorporated
1 Year 5 Months Ago on 29 Apr 2024
Get Alerts
Get Credit Report
Discover Re-Aim Therapeutics Ltd's Credit Score, how much credit you can offer them, and how likely they are to repay you
See All Credit Score & Limits
Documents
Resolutions
Submitted on 10 Oct 2025
Memorandum and Articles of Association
Submitted on 10 Oct 2025
Memorandum and Articles of Association
Submitted on 10 Oct 2025
Current accounting period shortened from 30 April 2026 to 31 March 2026
Submitted on 9 Oct 2025
Appointment of Mr Pierre-Louis Emmanuel Joffrin as a director on 2 October 2025
Submitted on 7 Oct 2025
Appointment of Mr Roel Bulthuis as a director on 2 October 2025
Submitted on 7 Oct 2025
Appointment of Mr John Tsai as a director on 2 October 2025
Submitted on 7 Oct 2025
Appointment of Mr Justian Craig Fox as a director on 2 October 2025
Submitted on 7 Oct 2025
Termination of appointment of Jason Goldstein as a director on 2 October 2025
Submitted on 7 Oct 2025
Statement of capital following an allotment of shares on 3 October 2025
Submitted on 7 Oct 2025
Explore All Documents
Repayment History
Understand how businesses repay their debts and see how they're performing year‐on‐year
See All Charges & CCJs